Phase Iii Study Of Tislelizumab Plus Chemotherapy Vs Chemotherapy Alone As First-Line (1l) Treatment For Advanced Squamous Non-Small Cell Lung Cancer (Sq Nsclc).

JOURNAL OF CLINICAL ONCOLOGY(2020)

引用 13|浏览25
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要